S.Amdt. 2034

SA 2034. Ms. WARREN (for herself and Mr. Rubio) submitted an
amendment intended to be proposed to amendment SA 1502 proposed by Mr.
Schumer to the bill S. 1260, to establish a new Directorate for
Technology and Innovation in the National Science Foundation, to
establish a regional technology hub program, to require a strategy and
report on economic security, science, research, innovation,
manufacturing, and job creation, to establish a critical supply chain
resiliency program, and for other purposes; which was ordered to lie on
the table; as follows:

At the end of title III of division E, add the following:

SEC. 5311. REPORT ON FOREIGN INVESTMENT FROM THE PEOPLE'S
REPUBLIC OF CHINA IN PHARMACEUTICAL INDUSTRY.

(a) In General.--Not later than one year after the date of
the enactment of this Act,

[[Page S3513]]

and annually thereafter, the Federal Trade Commission, in
consultation with the Secretary of Commerce, shall submit to
the appropriate congressional committees, the Secretary of
Health and Human Services, the Committee on Foreign
Investment in the United States, and the Commissioner of Food
and Drugs, a report on foreign investment from the People's
Republic of China in the pharmaceutical industry of the
United States.
(b) Elements.--The report required by subsection (a) shall
include an assessment of--
(1) the supply chain of the pharmaceutical industry of the
United States and the effect of concentration and reliance on
manufacturing in the People's Republic of China within that
industry;
(2) the effect of foreign investment from the People's
Republic of China in the pharmaceutical industry of the
United States on domestic capacity to produce drugs and
active and inactive ingredients of drugs; and
(3) the effect of foreign investment from the People's
Republic of China in technologies or other products for
sequencing or storage of DNA, including genome and exome
analysis, in the United States, including the effect of such
investment on the capacity to sequence or store DNA in the
United States.
(c) Authority.--The Federal Trade Commission shall have
authority under section 6 of the Federal Trade Commission Act
(15 U.S.C. 46) to conduct the studies required to prepare the
report required by subsection (a).
(d) Publication.--The Federal Trade Commission shall
publish an unclassified summary of the report required by
subsection (a) on a publicly available internet website of
the Commission.
(e) Appropriate Congressional Committees Defined.--In this
section, the term ``appropriate congressional committees''
means--
(1) the Committee on Banking, Housing, and Urban Affairs,
the Committee on Health, Education, Labor, and Pensions, the
Committee on Armed Services, the Committee on Foreign
Relations, the Committee on Commerce, Science, and
Transportation, and the Committee on Appropriations of the
Senate; and
(2) the Committee on Financial Services, the Committee on
Energy and Commerce, the Committee on Armed Services, the
Committee on Foreign Affairs, and the Committee on
Appropriations of the House of Representatives.
______